Perrigo (PRGO) Misses Q2 EPS by 5c; Guides FY16 EPS Below Views

Go back to Perrigo (PRGO) Misses Q2 EPS by 5c; Guides FY16 EPS Below Views

Leerink Partners Remains Sidelined on Perrigo (PRGO) Following Mixed 2Q

August 11, 2016 9:00 AM EDT

Leerink Partners maintained a Market Perform rating on Perrigo Co. (NYSE: PRGO), and cut the price target to $81.00 (from $96.00), following the company's 2Q earnings report. PRGO reported a modest beat on top line, but missed EPS by 3%.

Analyst Jason Gerberry commented,... More

Perrigo (PRGO) Announces Completion of Vitamins, Minerals & Supplements Business Divestiture

August 8, 2016 8:13 AM EDT

Perrigo Company plc (NYSE: PRGO) announced that it has completed the previously announced divestiture of its U.S. Vitamins, Minerals & Supplements (VMS) business to International Vitamin Corporation (IVC).

... More